首页> 美国卫生研究院文献>OncoTargets and therapy >Restoration of miR-26b expression partially reverses the cisplatin resistance of NSCLC by targeting tafazzin

【2h】

Restoration of miR-26b expression partially reverses the cisplatin resistance of NSCLC by targeting tafazzin

机译：通过靶向tafazzin恢复miR-26b表达可部分逆转NSCLC的顺铂耐药性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundDysregulation of microRNAs has been reported to be responsible for drug resistance of cancers. However, the association between aberrant expression of miR-26b and cisplatin resistance in non-small cell lung cancer (NSCLC) remains unclear.

机译：背景技术据报道，microRNA的失调是导致癌症耐药的原因。然而，在非小细胞肺癌（NSCLC）中，miR-26b的异常表达与顺铂耐药性之间的关系仍不清楚。

著录项

期刊名称 OncoTargets and therapy
作者
Shuzhi Zang; Shasha Zhao; Xinyuan Gao; Yunxia Li; Chunlei Zhong; Jianlian Gao;
展开▼
作者单位

展开▼
年(卷),期 2019(12),-1
年度 2019
页码 7551–7560
总页数 10
原文格式 PDF
正文语种
中图分类应用微生物学;肿瘤学;
关键词
NSCLC cisplatin resistance miR-26b TAZ;

机译：NSCLC;顺铂;耐药性;miR-26b;TAZ;

相似文献

外文文献
中文文献
专利

1. Restoration of miR-26b expression partially reverses the cisplatin resistance of NSCLC by targeting tafazzin [J] . Shuzhi Zang, Shasha Zhao, Xinyuan Gao, OncoTargets and therapy . 2019,第1期

机译：通过靶向tafazzin恢复miR-26b表达可部分逆转NSCLC的顺铂耐药性
2. Acquired cisplatin resistance in the head-neck cancer cell line Cal27 is associated with decreased DKK1 expression and can partially be reversed by overexpression of DKK1. [J] . Gosepath EM, Eckstein N, Hamacher A, International Journal of Cancer =: Journal International du Cancer . 2008,第9期

机译：头颈部癌细胞系Cal27中获得的顺铂耐药性与DKK1表达降低有关，并且可以通过DKK1的过表达而部分逆转。
3. MCL-1 is the key target of adjuvant chemotherapy to reverse the cisplatin-resistance in NSCLC [J] . Ma Jun, Zhao Zhenxian, Wu Kaiming, Gene: An International Journal Focusing on Gene Cloning and Gene Structure and Function . 2016,第2期

机译：MCL-1是辅助化疗逆转非小细胞肺癌对顺铂耐药的关键靶标
4. Survivin of Antisense Oligodeoxynucleotides Reverse Apoptotic Resistance Induced by Cisplatin in Lung Cells [C] . Zhang Zhi-wei, Jiang Dong, Ge Jin-feng, 2010 4th International Conference on Bioinformatics and Biomedical Engineering . 2010

机译：顺铂诱导的肺细胞反义寡核苷酸Survivin逆转凋亡抗性。
5. Yu Ping Feng San, an Ancient Chinese Herbal Decoction, Reverses Cisplatin-Induced Multi-Drug Resistance in Lung Cancer Cells: Mechanistic Evaluation and Development of New Formula [D] . Lou, Jianshu 2018

机译：俞平风散，一种古老的中药汤剂，逆转顺铂诱导的肺癌细胞多药耐药性：新药的机械评价和开发
6. Overexpression of miR-26b decreases the cisplatin-resistance in laryngeal cancer by targeting ATF2 [O] . Linli Tian, Jiarui Zhang, Xiuxia Ren, 2017

机译：miR-26b的过表达通过靶向ATF2降低喉癌的顺铂耐药性
7. Overexpression of miR-26b decreases the cisplatin-resistance in laryngeal cancer by targeting ATF2 [O] . Linli Tian, Jiarui Zhang, Xiuxia Ren, 2017

机译：miR-26b的过度表达通过靶向ATF2降低喉癌中的顺铂抗性

Restoration of miR-26b expression partially reverses the cisplatin resistance of NSCLC by targeting tafazzin

摘要

著录项

相似文献

相关主题

期刊订阅